Rare diseases
Investigational molecules
Locations
461 conditions with trials, the busiest first
1 397 trials across Europe, recruiting first
Orforglipron for stress urinary incontinence in women with obesity or overweight
CzechiaA Randomized Trial of lu af28996 dh1 to Reduce Motor Fluctuations in Adults with Parkinson’s Disease
CzechiaPhase 3 Study of Pitolisant for Excessive Daytime Sleepiness in Narcolepsy Patients
BelgiumA Phase 3 Randomized Study of Rozanolixizumab for Safety and Efficacy in Adults with Ocular Myasthenia Gravis
FranceEfficacy and Safety of ALKS 2680 and Alixorexton in Adults with Narcolepsy Type 1
AustriaPhase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2
AustriaSafety Study of NB-4746 with Riluzole and Placebo in Adults with Amyotrophic Lateral Sclerosis (ALS)
ItalyPhase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1
AustriaPhase 2 Randomized Study of Povetacicept to Assess Safety and Effectiveness in Adults with Generalized Myasthenia Gravis
PolandOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
AustriaA study to evaluate the safety and effectiveness of dextromethorphan, deramciclane fumarate, and deramciclane in treating agitation in people with Alzheimer's disease
CzechiaA study to evaluate the effectiveness and safety of pridopidine hydrochloride in patients with amyotrophic lateral sclerosis
BelgiumThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
